These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1360937)

  • 1. Conservative treatment of acute pancreatitis: the use of somatostatin.
    Ladas SD; Raptis SA
    Hepatogastroenterology; 1992 Oct; 39(5):466-9. PubMed ID: 1360937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Kaplan O
    J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of acute pancreatitis with somatostatin.
    Raptis SA; Ladas SD
    Scand J Gastroenterol Suppl; 1994; 207():34-8. PubMed ID: 7701265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.
    Paran H; Klausner J; Siegal A; Graff E; Freund U; Kaplan O
    J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delayed administration of octreotide in acute experimental pancreatitis.
    Kaplan O; Kaplan D; Casif E; Siegal A; Paran H; Graf E; Skornick Y
    J Surg Res; 1996 Apr; 62(1):109-17. PubMed ID: 8606496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
    Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
    Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
    J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of octreotide and somatostatin in acute and chronic pancreatitis.
    Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
    Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on the therapeutic effects of SMS201-995 on bile-induced acute pancreatitis in the dog].
    Satoh M
    Hokkaido Igaku Zasshi; 1998 Jan; 73(1):37-46. PubMed ID: 9546145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of somatostatin and octreotide in the management of acute pancreatitis.
    Büchler MW; Binder M; Friess H; Malfertheiner P
    Digestion; 1994; 55 Suppl 1():16-9. PubMed ID: 7907565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin and octreotide in the management of acute variceal hemorrhage.
    Avgerinos A; Armonis A; Raptis S
    Hepatogastroenterology; 1995 Apr; 42(2):145-50. PubMed ID: 7672763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of somatostatin and the somatostatin analogue octreotide as therapeutic agents in gastrointestinal disorders.
    Masclee AA; Jansen JB; Lamers CB
    Neth J Med; 1991 Dec; 39(5-6):356-65. PubMed ID: 1687076
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of somatostatin analogue on experimental pancreatic lesions and their sequelae].
    Tulassay Z; Németh J; Varga G; Papp M
    Orv Hetil; 1991 Jul; 132(30):1631-8. PubMed ID: 1866157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.
    Büchler MW; Binder M; Friess H
    Gut; 1994; 35(3 Suppl):S15-9. PubMed ID: 7911442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
    Delmont J; Hastier P; Dumas R
    Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
    [No Abstract]   [Full Text] [Related]  

  • 20. Somatostatin and somatostatin analogues--are they indicated in the management of acute pancreatitis?
    McKay CJ; Imrie CW; Baxter JN
    Gut; 1993 Nov; 34(11):1622-6. PubMed ID: 7902312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.